Multiplex PCR assay to identify clinically important <i>Aeromonas</i> species
Aki Sakurai(Fujita Health University), Masahiro Suzuki(Fujita Health University), Yasufumi Matsumura(Kyoto University), Sho Saito(National Center for Global Health and Medicine), Naoya Itoh(Aichi Cancer Center), Ryota Hase(Fujita Health University), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Sohei Harada(University of Tokyo Hospital), Kazuhiro Ishikawa(Edogawa Hospital), Naoto Hosokawa(Kameda Medical Center), Yohei Doi(Fujita Health University), Takehiro Hashimoto(Oita University Hospital), Takayuki Sakurai(Kanazawa University)
Cited by 5
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in <i>Shigella flexneri</i> 2b
|Antimicrobial Agents and Chemotherapy|2005|290
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
|Journal of Infection|2020|197